Alemtuzumab Compared with Chlorambucil as First-Line Therapy for Chronic Lymphocytic Leukemia

Reviewer: John P. Plastaras, MD, PhD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 17 de febrero del 2008

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015